LivingPhoenix Unveils Groundbreaking Biomimetic Collagen Technology

LivingPhoenix Regenerative Technologies has unveiled its innovative “Stable Triple-Helix Biomimetic Collagen” technology, marking a significant advance in collagen research. This breakthrough has garnered considerable attention, showcased at twelve prominent academic conferences throughout November 2025, focusing on aesthetic medicine, regenerative medicine, and personal care.

Academicians and industry experts have praised this development as a pivotal shift in collagen research, transitioning from traditional methods of “animal extraction” and “genetic recombination” to a focus on “structural design.” Many have hailed it as a revolutionary third-generation advancement, likening its importance to the “iPhone moment” in extracellular matrix research.

Key Presentations and Industry Reception

On October 31, during the 3rd Badachu Aesthetic Medicine Industry Forum, founder Qin Xingjiong elaborated on the innovation pathway that emphasizes compliance and ethical standards. His presentation received substantial acclaim from attendees and industry professionals.

At the subsequent “2025 10th Medical Collagen Industry Academic Conference,” chaired by Academician Liao Wanqing of the Chinese Academy of Engineering, Qin presented his findings in a report titled “Aqueous Polymer-Based Stable Triple-Helix Biomimetic Collagen”. Academician Zhang Qiqing from the Chinese Academy of Medical Sciences provided a notably positive review of the work.

The momentum continued on November 7, during the 2025 Scientists (International) Conference in Changsha. Qin introduced a new paradigm of “Structure-Driven Application,” which resonated with Nobel laureates and more than 3,000 professionals from around the globe. On the same day, LivingPhoenix launched the Smartender Bouncy Bar at the CIIE Sichuan Pavilion, distributing nearly 1,000 trial kits. The feedback was overwhelmingly positive, with users expressing excitement about its effectiveness.

International Expansion and Ethical Commitment

In addition to its domestic success, LivingPhoenix is making strides on the international stage. The company has been invited to join as a Council Member of the Global Aesthetic Medicine and Health Organization. Its team recently traveled to Indonesia, where they presented the core advantages of their technology to Mr. Jeffri Ardiyanto from the Ministry of Health. This includes the technology’s animal-free, ethical nature, fully compliant with Islamic Halal requirements. The presentation received encouraging responses from officials.

LivingPhoenix also secured meetings with a Presidential Special Envoy and several members of Parliament, indicating strong governmental interest in their technology.

At the MediCosme 2025 International Injectable Aesthetic Technology Innovation Conference, Qin chaired a forum where Professor Xiao Jianxi, a PhD supervisor at Lanzhou University, remarked, “Animal-derived collagen is ancient yet modern, recombinant collagen is youthful and vibrant, while biomimetic collagen represents the future.”

As LivingPhoenix continues to push the boundaries of collagen research, it is guided by its core principle of “Biomimetic Collagen + ECM Reconstruction.” The company aims to embody the vision of “Cell House — Where Regeneration Begins,” showcasing the potential of innovations “Created in China” to a global audience.